NEFL and myeloid sarcoma: Longitudinal change in BICAMS subtest scores was calculated and its associations with NfL concentration, disability measures and demographic/clinical data were analyzed.<h4>Results</h4>All PwMS were diagnosed with relapsing MS and 78.1% were started on platform DMTs, while the rest were prescribed higher-efficacy DMTs.